Comparative evaluation of open flap debridement alone and in combination with anorganic bone matrix/cell-binding peptide in the treatment of human infrabony defects: A randomized clinical trial

Pratima Ram Niwas Mishra, Abhay Pandurang Kolte, Rajashri Abhay Kolte, Natasha Gev Pajnigara, Kanan Ketan Shah, Pratima Ram Niwas Mishra, Abhay Pandurang Kolte, Rajashri Abhay Kolte, Natasha Gev Pajnigara, Kanan Ketan Shah

Abstract

Background: The synthetic anorganic bone matrix/cell-binding peptide (ABM/P-15) has displayed an increased fibroblast migration and attachment with bone graft material, thus enhancing periodontal regeneration. The objective of the present study was to evaluate and to correlate the efficacy of open flap debridement (OFD) with and without ABM/P-15 in the treatment of human infrabony periodontal defects.

Materials and methods: A total of 20 chronic periodontitis patients with equal number infrabony defects were randomly selected and assigned into two groups depending on the treatment received: Control group (treated with OFD) and Test group (treated with OFD + ABM/P-15). Clinical parameters recorded included plaque index, gingival index, probing pocket depth (PPD), clinical attachment level (CAL), gingival recession, and radiographic defect depth (RDD) which were evaluated at baseline and 6 months postsurgically.

Results: When compared to baseline, both the treatment groups demonstrated improvements in the clinical parameters at 6 months. Test group exhibited a mean PPD reduction of 4.15 ± 1.04 mm, CAL gain of 3.10 ± 1.42 mm, and reduction in RDD of 1.90 ± 0.72 mm postoperatively at 6 months. In contrast to Control group, the Test group showed greater reduction in PPD (P < 0.05) which was statistically significant, greater CAL gain and greater mean RDD reduction (P < 0.001) which was highly significant.

Conclusion: In the surgical management of periodontal infrabony defects, Test group elicited in statistically significant PPD reduction, CAL gain, and better infrabony defect fill at 6 months' postoperatively.

Keywords: Cell-binding peptide P-15; intrabony defects; periodontal regeneration; periodontitis.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Consort flowchart
Figure 2
Figure 2
Surgical protocol for Test group (ABM/P-15): (a) Baseline clinical measurement. (b) Full-thickness flap elevated. (c) ABM/P-15 graft placement following thorough debridement and presuturing. (d) Flap repositioning to preoperative level. (e) Postoperative clinical measurement of the treated area after 6 months. OFD – Open flap debridement; RDD – Radiographic defect depth; ABM/P-15 – Anorganic bone matrix/cell-binding peptide
Figure 3
Figure 3
Radiographic measurement following treatment in control (OFD) group: (a) OFD baseline RDD. (b) OFD 6 months postoperative, radiographic defect depth. OFD – Open flap debridement; RDD – Radiographic defect depth
Figure 4
Figure 4
Radiographic measurement following treatment in test (OFD + ABM/P-15) group: (a) ABM/P-15 baseline RDD. (b) ABM/P-15, 6 months postoperative radiographic defect depth. OFD – Open flap debridement; RDD – Radiographic defect depth; ABM/P-15 – Anorganic bone matrix/cell-binding peptide

References

    1. Zander HA, Polson AM, Heijl LC. Goals of periodontal therapy. J Periodontol. 1976;47:261–6.
    1. American Academy of Periodontology. Glossary of Periodontal Terms. 3rd ed. Chicago: American Academy of Periodontology; 1992.
    1. Pandit N, Sharma A, Jain A, Bali D, Malik R, Gugnani S, et al. The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study. J Indian Soc Periodontol. 2015;19:545–53.
    1. Kher VK, Bhongade ML, Shori TD, Kolte AP, Dharamthok SB, Shrirao TS, et al. A comparative evaluation of the effectiveness of guided tissue regeneration by using a collagen membrane with or without decalcified freeze-dried bone allograft in the treatment of infrabony defects: A clinical and radiographic study. J Indian Soc Periodontol. 2013;17:484–9.
    1. Stephan EB, Jiang D, Lynch S, Bush P, Dziak R. Anorganic bovine bone supports osteoblastic cell attachment and proliferation. J Periodontol. 1999;70:364–9.
    1. Yang XB, Bhatnagar RS, Li S, Oreffo RO. Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng. 2004;10:1148–59.
    1. Yukna R, Salinas TJ, Carr RF. Periodontal regeneration following use of ABM/P-1 5: A case report. Int J Periodontics Restorative Dent. 2002;22:146–55.
    1. Bhatnagar RS, Qian JJ, Wedrychowska A, Sadeghi M, Wu YM, Smith N, et al. Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng. 1999;5:53–65.
    1. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine C. J Periodontol. 1970;41:41–3.
    1. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533–51.
    1. Cohen RE, Mullarky RH, Noble B, Comeau RL, Neiders ME. Phenotypic characterization of mononuclear cells following anorganic bovine bone implantation in rats. J Periodontol. 1994;65:1008–15.
    1. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M, et al. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings. J Periodontol. 2002;73:123–8.
    1. Bowers GM, Chadroff B, Carnevale R, Mellonig J, Corio R, Emerson J, et al. Histologic evaluation of new attachment apparatus formation in humans. Part I. J Periodontol. 1989;60:664–74.
    1. Yukna RA, Callan DP, Krauser JT, Evans GH, Aichelmann-Reidy ME, Moore K, et al. Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects 6-month results. J Periodontol. 1998;69:655–63.
    1. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M, et al. Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects 6-month results. J Periodontol. 2000;71:1671–9.
    1. Pradeep AR, Shetty SK, Garg G, Pai S. Clinical effectiveness of autologous platelet-rich plasma and peptide-enhanced bone graft in the treatment of intrabony defects. J Periodontol. 2009;80:62–71.
    1. Pajnigara NG, Kolte AP, Kolte RA, Pajnigara NG. Volumetric assessment of regenerative efficacy of demineralized freeze-dried bone allograft with or without amnion membrane in grade II furcation defects: A cone beam computed tomography study. Int J Periodontics Restorative Dent. 2017;37:255–62.
    1. Debnath T, Chakraborty A, Pal TK. A clinical study on the efficacy of hydroxyapatite – Bioactive glass composite granules in the management of periodontal bony defects. J Indian Soc Periodontol. 2014;18:593–600.
    1. Barros RR, Novaes AB, Jr, Roriz VM, Oliveira RR, Grisi MF, Souza SL, et al. Anorganic bovine matrix/p-15 “flow” in the treatment of periodontal defects: Case series with 12 months of follow-up. J Periodontol. 2006;77:1280–7.
    1. Nazareth CA, Cury PR. Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment isolated class I gingival recession of defects: A pilot study. J Periodontol. 2011;82:700–7.
    1. Eto AL, Joly JC, Jeffcoat M, de Araújo NS, de Araújo VC, Cury PR, et al. Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: A clinical and radiographic study in humans. J Periodontol. 2007;78:2277–83.
    1. Pajnigara N, Kolte A, Kolte R, Pajnigara N, Lathiya V. Diagnostic accuracy of cone beam computed tomography in identification and postoperative evaluation of furcation defects. J Indian Soc Periodontol. 2016;20:386–90.

Source: PubMed

Подписаться